Editorial: anti-TNF therapy-a double-edged sword? Authors' reply
Aliment Pharmacol Ther
.
2019 Oct;50(7):823-824.
doi: 10.1111/apt.15459.
Authors
Joshua Korzenik
1
2
,
Michael Due Larsen
3
4
,
Jan Nielsen
3
4
,
Jens Kjeldsen
5
6
,
Bente Mertz Nørgård
1
2
3
4
Affiliations
1
Division of Gastroenterology, Hepatology, and Endoscopy, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
2
Harvard Medical School, Boston, Massachusetts.
3
Center for Clinical Epidemiology, Odense University Hospital, Odense, Denmark.
4
Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
5
Department of Medical Gastroenterology S, Odense University Hospital, Odense, Denmark.
6
Research Unit of Medical Gastroenterology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
PMID:
31532552
DOI:
10.1111/apt.15459
No abstract available
Publication types
Editorial
Comment
MeSH terms
Autoimmune Diseases*
Colitis, Ulcerative*
Crohn Disease*
Etanercept
Humans
Inflammatory Bowel Diseases*
Tumor Necrosis Factor-alpha
Substances
Tumor Necrosis Factor-alpha
Etanercept